Articles
1
-
20
of
48
- Researchers in Galway battle against cancer on many fronts
Mon, May 21, 2012 INNOVATION PROFILE: Cancer research at NUI Galway: FOR REASONS which are still a matter of conjecture and research, the people in the west of Ireland have significantly higher rates of breast and prostate cancer than the rest of the Irish population. - Alkermes biotech group doubles revenues for year to end MarchFri, May 18, 2012THE MERGER with Elan Drug Technologies and a strong performance by its portfolio of drugs saw biotech group Alkermes report a more than doubling of revenues for the year to March 31st last.
- Galway firm wins award for surgical imaging technologyThu, May 17, 2012A Galway-based medical device developer, Crospon, has won a European award for its surgical imaging technology.
- Cork jobs boost
Tue, May 15, 2012PRIVATE HEALTH insurance firm Laya Healthcare is to create 100 jobs in Cork over the next three years, writes
CIARA O’BRIEN - Laya to create 100 jobs in CorkMon, May 14, 2012Private health insurance firm Laya Healthcare is to create 100 jobs in Cork over the next three years.
- New 'nanoscope' to help early detection of Alzheimer'sMon, May 14, 2012IRISH RESEARCHERS are leading a €5.4 million international effort to develop a “nanoscope” that will be able to study brain tissues without surgery or damage. They hope to be able to use the nanoscope in the early detection of Alzheimer’s disease.
- Irish firm partners with start-up on vaccine deliveryMon, May 14, 2012SOFTWARE START-UP Incaplex, which specialises in travel medicine, has entered into a partnership with Irish-owned healthcare software company Helix Health. The move is to integrate its travel vaccination application into Helix’s pharmacy and GP software packages.
- United Drug profits rise 7%Thu, May 10, 2012PHARMACEUTICAL AND healthcare services group United Drug has reported a 7 per cent rise in pre-tax profits for the six months to the end of March 2012.
- GSK takes Human Genome Sciences offer to shareholdersThu, May 10, 2012GlaxoSmithKline will take its $2.6 billion (€2 billion) bid for long-time partner Human Genome Sciences directly to shareholders this week, after its takeover offer was rejected last month by the US biotech group’s board.
- Monitoring discharged hospital patients by the phrases they useThu, May 10, 2012 START-UP NATION: Software developer Cara Health: Software that detects the likelihood of a patient needing readmittance to hospital by the phrases they use has healthy prospects
- United Group profits up 7 per centWed, May 9, 2012Pharmaceutical and healthcare services group United Drug has reported a 7 per cent rise in pre-tax profits for the six-months to the end of March 2012.
- Cork probiotic specialist extends P&G dealTue, May 8, 2012IRISH BIOTECH group Alimentary Health is extending the terms of its partnership with Procter & Gamble (P&G) as it looks to expand the reach of its probiotic therapies for gastro-intestinal and inflammatory conditions.
- Boston Scientific win US approval for pacemakersTue, May 8, 2012BOSTON SCIENTIFIC’S Ingenio and Advantio pacemakers won US approval to treat abnormally slow heartbeats, clearing the way for sales of devices that have been in development for a decade in the $4 billion global market.
- Roche ends efforts to develop heart drugTue, May 8, 2012SWISS DRUGMAKER Roche has ended efforts to develop a heart disease drug which some industry analysts had estimated could have achieved $10 billion in annual sales, after poor results from a late-stage trial.
- TCD spin-off will teach the world to handwash
Mon, May 7, 2012 HEALTHCARE: AN INNOVATIVE hand-washing e-training system developed by a small Irish company forms part of a new global hand hygiene campaign announced by the World Health Organisation (WHO) during the weekend aimed at reducing deaths from hospital acquired infections (IFAs). - Biotrin purchase to drive businessSat, May 5, 2012Dublin headquartered medical devices firm Biotrin has signed a €7.6 million deal to buy technologies that will drive its molecular diagnostics business.
- Profit up at Blackrock Medical PartnersSat, May 5, 2012Blackrock Medical Partners, a company owned by James Sheehan and his son Josep, has reported a €78,000 rise in its profit and loss account in 2010.
- Quinn becomes Laya as buyout rebrandsWed, May 2, 2012Quinn Healthcare, the country’s second largest private health insurer, with 450,000 members, has changed its name to Laya.
- Pfizer reports drop in net income and profitsWed, May 2, 2012PFIZER, THE world’s largest drug company by revenues, reported a steep drop in first-quarter profits as the impact of losing exclusive rights to sell its top-selling drug, Lipitor, hit its bottom line.
- Warner Chilcott to explore strategic optionsTue, May 1, 2012SPECIALITY PHARMACEUTICAL company Warner Chilcott said yesterday it would explore strategic options, including preliminary talks with potential buyers, sending its shares up as much as 24 per cent.
